test

Delmer Dee Raibourn III

@Avidity Partners Management Lp

Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AZNAstrazeneca Plc
Recent Activity
Exited
0%
$15.988M
205,000 shares@ $77.99 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Exited
0%
$9.756M
215,600 shares@ $45.25 avg price
CYBNCybin Inc
Recent Activity
Exited
0%
$9.454M
34.884M shares@ $0.28 avg price
TYRATyra Biosciences Inc
Recent Activity
Exited
0%
$5.964M
373,000 shares@ $15.99 avg price
PATHUipath Inc
Recent Activity
Exited
0%
$4.59M
362,000 shares@ $12.68 avg price
SYRESpyre Therapeutics Inc
Recent Activity
Exited
0%
$4.584M
195,000 shares@ $23.51 avg price
IMTXImmatics N.v
Recent Activity
Exited
0%
$4.568M
393,100 shares@ $11.62 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
Exited
0%
$4.432M
93,000 shares@ $47.66 avg price
ABIOArca Biopharma Inc
Recent Activity
Exited
0%
$3.83M
1M shares@ $3.83 avg price
NTLAIntellia Therapeutics Inc
Recent Activity
Exited
0%
$3.805M
170,000 shares@ $22.38 avg price